Barnaby’s experience in building BioFidelity from the ground up (and being part of that same journey previously at Base4) offers valuable insights into the challenges and opportunities faced by founders.

As CEO and Co-Founder of BioFidelity, Barnaby understands these challenges. Since spinning out from Base4 and co-founding BioFidelity in 2019, he has built the company into a highly differentiated leader in the field of cancer diagnostics. BioFidelity’s mission is to develop ultra-sensitive, cost-effective molecular diagnostics that streamline the detection of actionable genetic mutations. This innovation has the potential to significantly improve the speed and accuracy of cancer treatment decisions, directly impacting patient outcomes on a global scale.

Building a team that can operate on an international scale is essential for success. Research by McKinsey & Company highlights that biotech firms with high-performing, diverse teams are better positioned to innovate and lead in international markets (McKinsey & Company) (McKinsey & Company). For founders, the ability to craft such teams is often a decisive factor in their venture's success.

In this session, Barnaby will discuss:

• The essential role you as the founder play in shaping a team capable of achieving global scale.

• How BioFidelity’s approach to team building has been integral to its success, with key lessons that can be applied by you.

• Insights into the specific challenges biotech startups face when expanding internationally, including securing investment and sustaining innovation in a competitive global market.